La companyia biotecnològica barcelonina Peptomyc ha tancat una ronda de finançament de 5,7 milions d'euros amb l'entrada de l'Institut Català de Finances (IC...
Peptomyc tanca una ronda de 5,7 milions amb l'entrada de l'ICF en el seu capital
La ronda la lidera un fons assessorat per Asabys
www.ara.cat
September 29, 2026 at 10:49 AM
La companyia biotecnològica barcelonina Peptomyc ha tancat una ronda de finançament de 5,7 milions d'euros amb l'entrada de l'Institut Català de Finances (IC...
📰 Peptomyc tanca una ronda de 5,7 M€ amb l’entrada de l’ICF en el seu accionariat
🔗 Més informació via @expansioncom.bsky.social
#ActualitatBioRegió
🔗 Més informació via @expansioncom.bsky.social
#ActualitatBioRegió
September 30, 2026 at 11:56 AM
📰 Peptomyc tanca una ronda de 5,7 M€ amb l’entrada de l’ICF en el seu accionariat
🔗 Més informació via @expansioncom.bsky.social
#ActualitatBioRegió
🔗 Més informació via @expansioncom.bsky.social
#ActualitatBioRegió
Ayer, 3 de diciembre, participé como ponente en la XV edición del @cniostopcancer.bsky.social Lab Day, contando mi experiencia científica y emprendedora en @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Muchas gracias a los estudiantes por invitarme! @msmelanoma.bsky.social
December 4, 2025 at 7:51 PM
Ayer, 3 de diciembre, participé como ponente en la XV edición del @cniostopcancer.bsky.social Lab Day, contando mi experiencia científica y emprendedora en @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Muchas gracias a los estudiantes por invitarme! @msmelanoma.bsky.social
Laura, cada vez que vienes al @cniostopcancer.bsky.social descubrimos facetas nuevas de ti, de omomyc y de tu trayectoria como emprendedora. Eres un ejemplo y una inspiración para todos!
Estamos atentos a los ensayos clínicos de #Peptomyc!!!
@vhio.bsky.social
Estamos atentos a los ensayos clínicos de #Peptomyc!!!
@vhio.bsky.social
Ayer, 3 de diciembre, participé como ponente en la XV edición del @cniostopcancer.bsky.social Lab Day, contando mi experiencia científica y emprendedora en @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Muchas gracias a los estudiantes por invitarme! @msmelanoma.bsky.social
December 4, 2025 at 8:47 PM
Laura, cada vez que vienes al @cniostopcancer.bsky.social descubrimos facetas nuevas de ti, de omomyc y de tu trayectoria como emprendedora. Eres un ejemplo y una inspiración para todos!
Estamos atentos a los ensayos clínicos de #Peptomyc!!!
@vhio.bsky.social
Estamos atentos a los ensayos clínicos de #Peptomyc!!!
@vhio.bsky.social
Honored to deliver a keynote today at the 19th Scientific Day & 29th Annual Conference of Vall d’Hebron on collaborative, challenge-driven research with transformative health impact. #MYC #OMO-103 #Omomyc
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc
December 4, 2025 at 7:56 PM
Honored to deliver a keynote today at the 19th Scientific Day & 29th Annual Conference of Vall d’Hebron on collaborative, challenge-driven research with transformative health impact. #MYC #OMO-103 #Omomyc
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc
Mil gracias a la @fundacionfero.bsky.social por su invitación a impartir una Charla Científica en el Circulo Ecuestre y contar el desarrollo de nuestra terapia para el tratamiento del cáncer.
🙏🏻 Gracias FERO por vuestro apoyo continuo a la investigación contra el cáncer! @vhio.bsky.social #peptomyc
🙏🏻 Gracias FERO por vuestro apoyo continuo a la investigación contra el cáncer! @vhio.bsky.social #peptomyc
October 18, 2025 at 8:42 AM
Mil gracias a la @fundacionfero.bsky.social por su invitación a impartir una Charla Científica en el Circulo Ecuestre y contar el desarrollo de nuestra terapia para el tratamiento del cáncer.
🙏🏻 Gracias FERO por vuestro apoyo continuo a la investigación contra el cáncer! @vhio.bsky.social #peptomyc
🙏🏻 Gracias FERO por vuestro apoyo continuo a la investigación contra el cáncer! @vhio.bsky.social #peptomyc
Un estudi coliderat per la #investigadoraICREA Laura Soucek @lsoucek.bsky.social (@lsouceklab.bsky.social) mostra que Omomyc —fàrmac creat per la spin-off d'ICREA i VHIO Peptomyc— pot ser una estratègia terapèutica per combatre el càncer de mama triple negatiu.
🔗Consulta la notícia: bit.ly/4pRdY6P
🔗Consulta la notícia: bit.ly/4pRdY6P
Un estudi liderat per Laura Soucek i Fabio Giuntini #VHIO mostra que combinar l’inhibidor de MYC Omomyc (del Peptomyc, VHIO &
@icreacommunity.bsky.social spin-off) amb teràpies dirigides a la reparació de l’ADN potencia l’activitat antitumoral en #càncerdemamatriplenegatiu
➡️ linke.to/OmomycVHIO_Cat
@icreacommunity.bsky.social spin-off) amb teràpies dirigides a la reparació de l’ADN potencia l’activitat antitumoral en #càncerdemamatriplenegatiu
➡️ linke.to/OmomycVHIO_Cat
Combinar l’inhibidor de MYC Omomyc amb teràpies dirigides a la reparació de l’ADN potencia la resposta antitumoral en mo
linke.to
December 4, 2025 at 9:07 AM
Un estudi coliderat per la #investigadoraICREA Laura Soucek @lsoucek.bsky.social (@lsouceklab.bsky.social) mostra que Omomyc —fàrmac creat per la spin-off d'ICREA i VHIO Peptomyc— pot ser una estratègia terapèutica per combatre el càncer de mama triple negatiu.
🔗Consulta la notícia: bit.ly/4pRdY6P
🔗Consulta la notícia: bit.ly/4pRdY6P
🔴 OMO-103, a drug developed by @peptomyc, will be tested as a therapy for patients with advanced osteosarcoma.
The trial is funded by the @OSInstitute and aims to evaluate the clinical activity, safety and pharmacodynamics ➡️ https://linke.to/OSTEOMYCVHIO
#OSTEOMYC
The trial is funded by the @OSInstitute and aims to evaluate the clinical activity, safety and pharmacodynamics ➡️ https://linke.to/OSTEOMYCVHIO
#OSTEOMYC
January 16, 2025 at 7:02 AM
🔴 OMO-103, a drug developed by @peptomyc, will be tested as a therapy for patients with advanced osteosarcoma.
The trial is funded by the @OSInstitute and aims to evaluate the clinical activity, safety and pharmacodynamics ➡️ https://linke.to/OSTEOMYCVHIO
#OSTEOMYC
The trial is funded by the @OSInstitute and aims to evaluate the clinical activity, safety and pharmacodynamics ➡️ https://linke.to/OSTEOMYCVHIO
#OSTEOMYC
Our news of the week: Poster presented at the first annual @sosclc-aecc.bsky.social Symposium, showcasing the work of Ana Lopez Garza and Hugo Thabussot on #SCLC research, conducted as part of the #AECC 70% Survivorship Challenge. @vhio.bsky.social #peptomyc
November 7, 2025 at 12:03 PM
Our news of the week: Poster presented at the first annual @sosclc-aecc.bsky.social Symposium, showcasing the work of Ana Lopez Garza and Hugo Thabussot on #SCLC research, conducted as part of the #AECC 70% Survivorship Challenge. @vhio.bsky.social #peptomyc
Enhorabuena @lsoucek.bsky.social y equipos en @vhio.bsky.social y #Peptomyc!!!
Convicción, perseverancia determinación y un durísimo esfuerzo (3 décadas) para llevar un resultado del laboratorio a ensayos clínicos. Con rigor y ética
#RoleModel
elpais.com/ciencia/2026...
@manuelansede.bsky.social
Convicción, perseverancia determinación y un durísimo esfuerzo (3 décadas) para llevar un resultado del laboratorio a ensayos clínicos. Con rigor y ética
#RoleModel
elpais.com/ciencia/2026...
@manuelansede.bsky.social
El larguísimo trecho desde la ‘cura’ del cáncer en ratones hasta las personas
La científica Laura Soucek, que eliminó tumores en roedores hace casi 20 años, invoca el “deber moral” de no generar falsas expectativas tras el anuncio de Mariano Barbacid
elpais.com
February 21, 2026 at 10:12 AM
Enhorabuena @lsoucek.bsky.social y equipos en @vhio.bsky.social y #Peptomyc!!!
Convicción, perseverancia determinación y un durísimo esfuerzo (3 décadas) para llevar un resultado del laboratorio a ensayos clínicos. Con rigor y ética
#RoleModel
elpais.com/ciencia/2026...
@manuelansede.bsky.social
Convicción, perseverancia determinación y un durísimo esfuerzo (3 décadas) para llevar un resultado del laboratorio a ensayos clínicos. Con rigor y ética
#RoleModel
elpais.com/ciencia/2026...
@manuelansede.bsky.social
Very proud to be one of the Catalan awardees of the @erc.europa.eu Proof of Concept grants.
The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera.
Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.
The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera.
Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.
February 6, 2026 at 9:01 AM
Very proud to be one of the Catalan awardees of the @erc.europa.eu Proof of Concept grants.
The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera.
Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.
The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera.
Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.
🔴 A #VHIO-led study led by Laura Soucek and Fabio Giuntini shows that combining the MYC inhibitor #Omomyc (by VHIO & @icreacommunity.bsky.social's #Peptomyc) the with DNA-repair–targeted therapies boosts anti-tumor activity in preclinical triple-negative #BreastCancer.
➡️ linke.to/OmomycVHIO
➡️ linke.to/OmomycVHIO
MYC targeting by Omomyc synergizes with PARP inhibition and potentiates antitumor response in preclinical models of trip
linke.to
December 2, 2025 at 11:51 AM
🔴 A #VHIO-led study led by Laura Soucek and Fabio Giuntini shows that combining the MYC inhibitor #Omomyc (by VHIO & @icreacommunity.bsky.social's #Peptomyc) the with DNA-repair–targeted therapies boosts anti-tumor activity in preclinical triple-negative #BreastCancer.
➡️ linke.to/OmomycVHIO
➡️ linke.to/OmomycVHIO
Encantada de participar en el Ennova Health Day representando a @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Gracias a la organización, #DiarioMédico y a los colegas de mesa por un debate inspirador. La innovación nace en y para el hospital.
November 19, 2025 at 8:02 PM
Encantada de participar en el Ennova Health Day representando a @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Gracias a la organización, #DiarioMédico y a los colegas de mesa por un debate inspirador. La innovación nace en y para el hospital.
Encantada de participar en el Ennova Health Day representando a @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Gracias a la organización, #DiarioMédico y a los colegas de mesa por un debate inspirador. La innovación nace en y para el hospital.
November 19, 2025 at 8:00 PM
Encantada de participar en el Ennova Health Day representando a @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Gracias a la organización, #DiarioMédico y a los colegas de mesa por un debate inspirador. La innovación nace en y para el hospital.
Last week in San Francisco was intense, productive, and personally meaningful.
As CSO of #Peptomyc, , I joined our CEO @jesusmartingarcia.bsky.social during #JPMHealthcare week to meet with pharmaceutical companies and discuss potential strategic collaborations.
📍 San Francisco
As CSO of #Peptomyc, , I joined our CEO @jesusmartingarcia.bsky.social during #JPMHealthcare week to meet with pharmaceutical companies and discuss potential strategic collaborations.
📍 San Francisco
January 18, 2026 at 10:32 AM
Last week in San Francisco was intense, productive, and personally meaningful.
As CSO of #Peptomyc, , I joined our CEO @jesusmartingarcia.bsky.social during #JPMHealthcare week to meet with pharmaceutical companies and discuss potential strategic collaborations.
📍 San Francisco
As CSO of #Peptomyc, , I joined our CEO @jesusmartingarcia.bsky.social during #JPMHealthcare week to meet with pharmaceutical companies and discuss potential strategic collaborations.
📍 San Francisco
Really happy to share our new open-access review in Frontiers in Cell and Developmental Biology 🎉
#MYC inhibition creates vulnerabilities that can be targeted with #DDR inhibitors.
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc @lsouceklab.bsky.social
www.frontiersin.org/journals/cel...
#MYC inhibition creates vulnerabilities that can be targeted with #DDR inhibitors.
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc @lsouceklab.bsky.social
www.frontiersin.org/journals/cel...
Frontiers | The leading role of MYC in DNA damage response: exploring opportunities for therapeutic inhibition
MYC performs a dual role in DNA Damage Response (DDR), promoting genomic instability through replication stress, R-loop formation, and topoisomerase-mediated...
www.frontiersin.org
January 5, 2026 at 10:59 AM
Really happy to share our new open-access review in Frontiers in Cell and Developmental Biology 🎉
#MYC inhibition creates vulnerabilities that can be targeted with #DDR inhibitors.
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc @lsouceklab.bsky.social
www.frontiersin.org/journals/cel...
#MYC inhibition creates vulnerabilities that can be targeted with #DDR inhibitors.
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc @lsouceklab.bsky.social
www.frontiersin.org/journals/cel...
L'empresa biotecnològica Peptomyc continua avançant en el desenvolupament del seu fàrmac contra el càncer. La seva cofundadora, Laura Soucek, fa dècades que estudia ...
Peptomyc aconsegueix 5 M€ per al seu fàrmac contra el càncer
El finançament servirà per completar els estudis clínics en marxa
www.ara.cat
March 25, 2026 at 1:33 PM
L'empresa biotecnològica Peptomyc continua avançant en el desenvolupament del seu fàrmac contra el càncer. La seva cofundadora, Laura Soucek, fa dècades que estudia ...
Huge thanks to Fabio Giuntini, and to the entire teams at
@vhio.bsky.social and #peptomyc for making this possible. We also want to acknowledge the support of
#AECMM and the @erc.europa.eu for backing research that can make a real difference.
@vhio.bsky.social and #peptomyc for making this possible. We also want to acknowledge the support of
#AECMM and the @erc.europa.eu for backing research that can make a real difference.
December 3, 2025 at 6:56 AM
Huge thanks to Fabio Giuntini, and to the entire teams at
@vhio.bsky.social and #peptomyc for making this possible. We also want to acknowledge the support of
#AECMM and the @erc.europa.eu for backing research that can make a real difference.
@vhio.bsky.social and #peptomyc for making this possible. We also want to acknowledge the support of
#AECMM and the @erc.europa.eu for backing research that can make a real difference.
For years, #RAS and #MYC were considered "undruggable." The success of RAS has changed the conversation. Proud to see this recent @nature.com News & Views highlighting MYC as a promising next frontier and #Peptomyc as a key player helping advance the field. www.nature.com/articles/d41...
Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments
Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumours will be next.
www.nature.com
June 3, 2026 at 10:16 AM
For years, #RAS and #MYC were considered "undruggable." The success of RAS has changed the conversation. Proud to see this recent @nature.com News & Views highlighting MYC as a promising next frontier and #Peptomyc as a key player helping advance the field. www.nature.com/articles/d41...
“By conducting this study, we hope to gain valuable insights that will ultimately lead to improved outcomes for cancer patients.”
- Dr. Charles Lopez on a new clinical trial to evaluate OMO-103 in patients with a form of #PancreaticCancer: www.peptomyc.com/peptomyc-ann...
- Dr. Charles Lopez on a new clinical trial to evaluate OMO-103 in patients with a form of #PancreaticCancer: www.peptomyc.com/peptomyc-ann...
December 13, 2024 at 6:45 PM
“By conducting this study, we hope to gain valuable insights that will ultimately lead to improved outcomes for cancer patients.”
- Dr. Charles Lopez on a new clinical trial to evaluate OMO-103 in patients with a form of #PancreaticCancer: www.peptomyc.com/peptomyc-ann...
- Dr. Charles Lopez on a new clinical trial to evaluate OMO-103 in patients with a form of #PancreaticCancer: www.peptomyc.com/peptomyc-ann...
Gracias a los ponentes invitados, @lsoucek.bsky.social , de @vhio.bsky.social y Peptomyc y @danimateria.bsky.social , por su compartir tan generosamente su conocimiento y experiencia. 👇🏻
December 11, 2025 at 2:47 PM
Gracias a los ponentes invitados, @lsoucek.bsky.social , de @vhio.bsky.social y Peptomyc y @danimateria.bsky.social , por su compartir tan generosamente su conocimiento y experiencia. 👇🏻
New review just out in Frontiers in Immunology! 🎉
We dive into how #MYC reshapes the tumor–immune interface to drive #immuneescape and resistance to #immunotherapy.
Open access here 👉 www.frontiersin.org/journals/imm...
@vhio.bsky.social @icreacommunity.bsky.social @lsouceklab.bsky.social #peptomyc
We dive into how #MYC reshapes the tumor–immune interface to drive #immuneescape and resistance to #immunotherapy.
Open access here 👉 www.frontiersin.org/journals/imm...
@vhio.bsky.social @icreacommunity.bsky.social @lsouceklab.bsky.social #peptomyc
Frontiers | MYC at the tumor–immune interface: mechanisms of immune escape and immunotherapy resistance
Immunotherapies have transformed cancer treatment by harnessing the immune system to recognize and eliminate malignant cells, offering durable clinical benef...
www.frontiersin.org
January 23, 2026 at 11:41 AM
New review just out in Frontiers in Immunology! 🎉
We dive into how #MYC reshapes the tumor–immune interface to drive #immuneescape and resistance to #immunotherapy.
Open access here 👉 www.frontiersin.org/journals/imm...
@vhio.bsky.social @icreacommunity.bsky.social @lsouceklab.bsky.social #peptomyc
We dive into how #MYC reshapes the tumor–immune interface to drive #immuneescape and resistance to #immunotherapy.
Open access here 👉 www.frontiersin.org/journals/imm...
@vhio.bsky.social @icreacommunity.bsky.social @lsouceklab.bsky.social #peptomyc
Honored to give the closing talk at the inaugural #GordonResearchConference (#GRC) on #Microproteins tomorrow in Castelldefels, Spain. Excited to share our latest work on developing a clinically viable MYC inhibitor and wrap up an incredible week of cutting-edge science. @vhio.bsky.social #peptomyc
August 20, 2025 at 9:07 AM
Honored to give the closing talk at the inaugural #GordonResearchConference (#GRC) on #Microproteins tomorrow in Castelldefels, Spain. Excited to share our latest work on developing a clinically viable MYC inhibitor and wrap up an incredible week of cutting-edge science. @vhio.bsky.social #peptomyc
Un estudi liderat per Laura Soucek i Fabio Giuntini #VHIO mostra que combinar l’inhibidor de MYC Omomyc (del Peptomyc, VHIO &
@icreacommunity.bsky.social spin-off) amb teràpies dirigides a la reparació de l’ADN potencia l’activitat antitumoral en #càncerdemamatriplenegatiu
➡️ linke.to/OmomycVHIO_Cat
@icreacommunity.bsky.social spin-off) amb teràpies dirigides a la reparació de l’ADN potencia l’activitat antitumoral en #càncerdemamatriplenegatiu
➡️ linke.to/OmomycVHIO_Cat
Combinar l’inhibidor de MYC Omomyc amb teràpies dirigides a la reparació de l’ADN potencia la resposta antitumoral en mo
linke.to
December 2, 2025 at 11:51 AM
Un estudi liderat per Laura Soucek i Fabio Giuntini #VHIO mostra que combinar l’inhibidor de MYC Omomyc (del Peptomyc, VHIO &
@icreacommunity.bsky.social spin-off) amb teràpies dirigides a la reparació de l’ADN potencia l’activitat antitumoral en #càncerdemamatriplenegatiu
➡️ linke.to/OmomycVHIO_Cat
@icreacommunity.bsky.social spin-off) amb teràpies dirigides a la reparació de l’ADN potencia l’activitat antitumoral en #càncerdemamatriplenegatiu
➡️ linke.to/OmomycVHIO_Cat
Un estudio liderado por Laura Soucek y Fabio Giuntini muestra que combinar el inhibidor de MYC Omomyc (de #Peptomyc, VHIO y
@icreacommunity.bsky.social spin-off) con terapias dirigidas a la reparación del ADN potencia la actividad antitumoral en #cáncerdemamatriplenegativo
➡️ linke.to/OmomycVHIO_C...
@icreacommunity.bsky.social spin-off) con terapias dirigidas a la reparación del ADN potencia la actividad antitumoral en #cáncerdemamatriplenegativo
➡️ linke.to/OmomycVHIO_C...
Combinar el inhibidor de MYC Omomyc con terapias dirigidas a la reparación del ADN potencia la respuesta antitumoral en
linke.to
December 2, 2025 at 11:51 AM
Un estudio liderado por Laura Soucek y Fabio Giuntini muestra que combinar el inhibidor de MYC Omomyc (de #Peptomyc, VHIO y
@icreacommunity.bsky.social spin-off) con terapias dirigidas a la reparación del ADN potencia la actividad antitumoral en #cáncerdemamatriplenegativo
➡️ linke.to/OmomycVHIO_C...
@icreacommunity.bsky.social spin-off) con terapias dirigidas a la reparación del ADN potencia la actividad antitumoral en #cáncerdemamatriplenegativo
➡️ linke.to/OmomycVHIO_C...